NCI-H1650 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF1152
Target Cell Organism: Human
Target Cell Alternative Name: H-1650; H1650
Target Cell Name: NCI-H1650
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide NCI-H1650-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H1650
Target Cell Organism
Human
Target Cell Background
NCI-H1650 [H-1650, H1650] is a cell line exhibiting epithelial morphology that was isolated in 1987 from the lung tissue of a 27-year-old, male smoker with stage 3B, bronchoalveolar carcinoma. Use these cells for your immuno-oncology and lung cancer research.
Target Cell Alternative Name
H-1650; H1650
Related Diseases
Lung Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry